Combination treatment with etanercept and an intensive SPA rehabilitation program in active ankylosing spondylitis

International Journal of Immunopathology and Pharmacology

Volumn 22, Issue 4, 2009, Pages 1125-1129

  Colina, Matteo ^a   Ciancio, G ^a   Garavini, R ^a,b   Conti, M ^a,b   Trotta, F ^a   Govoni, M ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b Presidio di Medicina Fisica e Riabilitazione Delle Terme di Castrocaro   (Italy)

Author keywords

Ankylosing spondylitis; BASFI; Etanercept; Quality of life; Rehabilitation

Indexed keywords

ETANERCEPT;

ANKYLOSING SPONDYLITIS; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MONOTHERAPY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; SPA TREATMENT; VISUAL ANALOG SCALE;

EID: 76349092691     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200902200430     Document Type: Article

References (15)

1. Gran JT, Husby G. The epidemiology of ankylosing spondylitis. Semin Arthritis Rheum 1993; 22:319-34.
2. Will R, Edmunds L, Elswood J, et al. Is there sexual inequality in ankylosing spondylitis? A study of 498 women and 1,202 men. J Rheumatol 1990; 17:1649-52.
3. Khan MA. Clinical features of ankylosing spondylitis. In: Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH, eds. Rheumatology, 3rd edn. Mosby, London 2003, 1161-81.
4. Sieper J, Braun J, Rudwaleit M, et al. Ankylosing spondylitis: an overview. Ann Rheum Dis 2002; 61(S):8-18.
5. Clegg DO, Reda DJ, Weisman MH, et al. Comparison of sulfasalazine and placebo in treatment of ankylosing spondylitis: a Depatments of Veteran Affairs cooperative study. Arthritis Rheum 1996; 39: 2004-12.
6. Dougados M, van der Linden S, Leirisalo-Repo M, et al. Sulfasalazine in the treatment of spondyloarthropathy: a randomized, multicenter, double-blind, placebo-controlled study. Arthritis Rheum 1995; 38:618-27.
7. Roychowdhury B, Bintley-Bagot S, Bulgen DY, et al. Is methotrexate effective in ankylosing spondylitis? Rheumatology 2002; 41:1330-2.
8. Gorman JD, Sack KE, Davis JC Jr. Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor a. N Engl J Med 2002; 346:1349-56.
9. Braun J, Brandt J, Listing J, et al. Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial. Lancet 2002; 359:1187-93.
10. Calin A, Dijkmans BA, Emery P, et al. Outcome of a multicentre randomised clinical trial of etanercept to treat ankylosing spondylitis. Ann Rheum Dis 2004; 63:1594-600.
11. Dagfinrud H, Kvien TK, Hagen KB. The Cochrane review of physiotherapy interventions for ankylosing spondylitis. J Rheumatol 2005; 32:1899-906.
12. Lubrano E, D'Angelo S, Parson WJ, et al. Effects of a combination treatment of an intensive rehabilitation program and etanercept in patients with ankylosing spondylitis: a pilot study. J Rheumatol 2006; 33: 2029-34.
13. Van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modifications of the New York criteria. Arthritis Rheum 1984; 27:361-8.
14. Zochling J, van der Heijde D, Burgos-Vargas R, et al. ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis 2006; 65:442-52.
15. Dubey SG, Leeder J, Gaffney K. Physical therapy in anti-TNF treated patients with ankylosing spondylitis. Rheumatology 2008; 47:1100-1.